Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis
- PMID: 34726075
- DOI: 10.2217/epi-2021-0296
Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis
Abstract
Aim: The exact epigenetic mechanisms that determine the balance of T helper (Th)1 and Th2 cells and autoimmune responses in multiple sclerosis (MS) remain unclear. We aim to clarify these. Methods: A combination of bioinformatics analysis and molecular evaluations was utilized to identify master hub genes. Results: A competitive endogenous RNA network containing six long noncoding RNAs (lncRNAs), 21 miRNAs and 86 mRNAs was provided through enrichment analysis and a protein-protein interaction network. NEAT1 and MALAT1 were found as differentially expressed lncRNAs using Gene Expression Omnibus (GSE21942). Quantitative real-time PCR results demonstrate dysregulation in the RUNX3 (a regulator of Th1/Th2 balance), GATA3 and TBX21, as well as miR-544a and miR-210-3p (which directly target RUNX3). ELISA also confirmed an imbalance in IFN-γ (Th1)/IL-4 (Th2) in MS patients. Conclusion: Our findings introduce novel biomarkers leading to Th1/Th2 imbalance in MS.
Keywords: RUNX3; Th1/Th2 imbalance; ceRNA network; miR-210-3p; miR-544a; multiple sclerosis; real-time PCR.
Plain language summary
Lay abstract Studies have shown that irregular control of noncoding RNAs (ncRNAs) in immune responses can lead to multiple sclerosis. T helper (Th)1 and Th2 cells balance plays an important role in regulating inflammation in this disease. In this study, to investigate the molecular factors that may disrupt this balance, we investigated the role of ncRNAs. Our results suggest that miR-210-3p and miR-544a irregularities can disrupt the Th1/Th2 balances through targeting the RUNX3 gene, which consequently leads to IFNγ/IL4 imbalance. It is also clarified that NEAT1 and MALAT1 long noncoding RNAs also have a role in this imbalance exerting their effect through miR-210-3p and miR-544a. This molecular pathway may provide significant information on multiple sclerosis disease development.
Similar articles
-
The potency of lncRNA MALAT1/miR-155/CTLA4 axis in altering Th1/Th2 balance of asthma.Biosci Rep. 2020 Feb 28;40(2):BSR20190397. doi: 10.1042/BSR20190397. Biosci Rep. 2020. Retraction in: Biosci Rep. 2023 Jun 28;43(6):BSR-2019-0397_RET. doi: 10.1042/BSR-2019-0397_RET. PMID: 31909418 Free PMC article. Retracted.
-
Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.J Periodontal Res. 2018 Aug;53(4):495-505. doi: 10.1111/jre.12539. Epub 2018 Mar 8. J Periodontal Res. 2018. PMID: 29516510
-
Long Non-Coding RNA- Associated Competing Endogenous RNA Axes in T-Cells in Multiple Sclerosis.Front Immunol. 2021 Dec 8;12:770679. doi: 10.3389/fimmu.2021.770679. eCollection 2021. Front Immunol. 2021. PMID: 34956196 Free PMC article.
-
Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases.Front Immunol. 2021 Oct 19;12:703936. doi: 10.3389/fimmu.2021.703936. eCollection 2021. Front Immunol. 2021. PMID: 34737736 Free PMC article. Review.
-
The role of non-coding RNAs in neuroinflammatory process in multiple sclerosis.Mol Neurobiol. 2022 Aug;59(8):4651-4668. doi: 10.1007/s12035-022-02854-y. Epub 2022 May 19. Mol Neurobiol. 2022. PMID: 35589919 Review.
Cited by
-
Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets.Pharmaceutics. 2023 Feb 22;15(3):728. doi: 10.3390/pharmaceutics15030728. Pharmaceutics. 2023. PMID: 36986586 Free PMC article. Review.
-
Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer.Curr Issues Mol Biol. 2023 Dec 5;45(12):9778-9792. doi: 10.3390/cimb45120611. Curr Issues Mol Biol. 2023. PMID: 38132457 Free PMC article. Review.
-
The Promotion of Humoral Immune Responses in Humans via SOCS1-Mediated Th2-Bias Following SARS-CoV-2 Vaccination.Vaccines (Basel). 2023 Nov 20;11(11):1730. doi: 10.3390/vaccines11111730. Vaccines (Basel). 2023. PMID: 38006062 Free PMC article.
-
MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs.Biomolecules. 2023 Mar 16;13(3):544. doi: 10.3390/biom13030544. Biomolecules. 2023. PMID: 36979479 Free PMC article.
-
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and Current Clinical Trials.Mol Neurobiol. 2025 Aug;62(8):10045-10090. doi: 10.1007/s12035-025-04868-8. Epub 2025 Apr 3. Mol Neurobiol. 2025. PMID: 40180689 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical